Research Analysts’ New Coverage for August 18th (BZ, DFTX, EDIT, ELVN, LBG, LEU, NUVB, OBX, RANI, SCTX)

Research Analysts’ new coverage for Tuesday, August 18th:

Bank of America Corporation assumed coverage on shares of KANZHUN (NASDAQ:BZ). Bank of America Corporation issued a neutral rating and a $19.00 target price on the stock.

Bank of America Corporation initiated coverage on shares of Definium Therapeutics (NASDAQ:DFTX). Bank of America Corporation issued a buy rating and a $75.00 target price on the stock.

LADENBURG THALM/SH SH began coverage on shares of Editas Medicine (NASDAQ:EDIT). The firm issued a buy rating and a $6.00 target price on the stock.

Barclays PLC began coverage on shares of Enliven Therapeutics (NASDAQ:ELVN). Barclays PLC issued an overweight rating and a $78.00 price target on the stock.

William Blair began coverage on shares of Enliven Therapeutics (NASDAQ:ELVN). They issued an outperform rating on the stock.

Canaccord Genuity Group Inc. initiated coverage on shares of LBG Media (LON:LBG). They issued a buy rating and a GBX 50 price target on the stock.

Barclays PLC began coverage on shares of Centrus Energy (NYSE:LEU). They issued an equal weight rating and a $207.00 target price on the stock.

JPMorgan Chase & Co. began coverage on shares of Nuvation Bio (NYSE:NUVB). JPMorgan Chase & Co. issued an overweight rating and a $13.00 price target on the stock.

Lifesci Capital assumed coverage on shares of Obsidian Therapeutics (NASDAQ:OBX). They issued an outperform rating and a $43.00 price target on the stock.

Chardan Capital started coverage on shares of Rani Therapeutics (NASDAQ:RANI). The firm issued a buy rating on the stock.

Leerink Partners assumed coverage on shares of Scribe Therapeutics (NASDAQ:SCTX). They issued an outperform rating and a $37.00 price target on the stock.

Canaccord Genuity Group Inc. assumed coverage on shares of Sinda (NYSE:SIND). The firm issued a speculative buy rating and a $19.00 price target on the stock.

Wolfe Research assumed coverage on shares of First Tracks Biotherapeutics (NASDAQ:TRAX). They issued an outperform rating and a $83.00 target price on the stock.

JPMorgan Chase & Co. started coverage on shares of WBI (NYSE:WBI). The firm issued an overweight rating and a $38.00 target price on the stock.

B. Riley Financial, Inc. started coverage on shares of Weave Communications (NYSE:WEAV). The firm issued a buy rating and a $8.25 target price on the stock.

Noble Financial assumed coverage on shares of Xerox (NASDAQ:XRX). They issued an outperform rating and a $5.00 target price on the stock.